Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > First Personalized CRISPR Treatment Gives Baby New Lease on Life
Tech and Science

First Personalized CRISPR Treatment Gives Baby New Lease on Life

Last updated: May 16, 2025 1:30 pm
Share
First Personalized CRISPR Treatment Gives Baby New Lease on Life
SHARE

In a groundbreaking development, a baby has become the first person to receive a personalized CRISPR gene-editing treatment for a devastating genetic disease. Little KJ Muldoon, who is almost ten months old, has shown positive progress after undergoing three doses of the gene-editing therapy. However, it is too early to determine if this treatment can be considered a definitive cure, according to Rebecca Ahrens-Nicklas, one of Muldoon’s physicians at Children’s Hospital of Philadelphia.

The therapy developed for Muldoon was specific to his genetic mutation and is unlikely to be applicable to other individuals. An international team of clinicians and researchers collaborated to create this bespoke treatment within a remarkably short period of six months. The drug, detailed in the New England Journal of Medicine, highlights the potential of personalized CRISPR therapies for rare genetic disorders.

While previous CRISPR treatments have targeted common genetic conditions like sickle-cell anemia, Muldoon’s therapy was uniquely tailored to address a specific mutation affecting his ability to process proteins. He inherited two mutations that hindered the production of a crucial enzyme, leading to high levels of ammonia in his blood and posing a severe risk to his health.

The traditional treatment for Muldoon’s condition would have been a liver transplant, but the urgency of his situation prompted his medical team to explore alternative options. Leveraging a CRISPR-based technique known as base editing, they devised a strategy to correct his genetic mutation through targeted DNA alterations. With the approval of Muldoon’s parents, the team embarked on an intensive research and development process, involving preclinical studies in animal models and collaboration with industry partners.

See also  Cleaned Alcohol, Baby Oil, Drugs After Diddy's Sex-Marathons: Ex-Assistant

After receiving the tailored gene-editing therapy, Muldoon demonstrated improved tolerance to protein intake and reduced dependence on medication to manage his condition. With each subsequent dose of the treatment, his clinicians have been able to gradually reduce his medication dosage, indicating promising results in his ongoing recovery.

While the success of Muldoon’s personalized CRISPR therapy offers hope for treating rare genetic diseases, challenges remain in scaling up such individualized treatments due to cost and logistical constraints. Nonetheless, the progress made in Muldoon’s case underscores the potential of CRISPR technology in revolutionizing precision medicine for genetic disorders.

As Muldoon continues to achieve milestones in his recovery, his parents are grateful for the advancements in medical science that have enabled their son to thrive. The journey of this pioneering gene-editing treatment serves as a beacon of hope for future applications of CRISPR therapies in addressing complex genetic conditions.

This article, originally published in Nature magazine on May 15, 2025, highlights the transformative impact of personalized CRISPR gene-editing treatments in the realm of rare genetic diseases.

TAGGED:babyCRISPRLeaseLifePersonalizedTreatment
Share This Article
Twitter Email Copy Link Print
Previous Article Trillions in Great Deals Secured for America Thanks to President Trump – The White House Trillions in Great Deals Secured for America Thanks to President Trump – The White House
Next Article Putin’s peace theatre keeps Trump watching — and Kyiv waiting Putin’s peace theatre keeps Trump watching — and Kyiv waiting
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

2 men seriously injured in Albany Park knife fight

A violent altercation in Albany Park resulted in two men being hospitalized with serious injuries…

April 26, 2025

Modifying Reciprocal Tariff Rates to Reflect Discussions with the People’s Republic of China – The White House

By virtue of the power granted to me as President, and in accordance with the…

May 12, 2025

Career criminal accused of shoving off-duty NYPD cop onto NYC subway tracks was recently cut loose after other assault

In a shocking incident late Tuesday in Manhattan, a homeless man allegedly pushed an off-duty…

September 24, 2025

These Are the 381 Books Removed From the Naval Academy Library

Maya Angelou’s iconic autobiography, "I Know Why the Caged Bird Sings," along with several books…

April 5, 2025

‘The Last of Us’ Season 2 Ratings: 5.3 Million Premiere Viewers

“The Last of Us” Season 2 Premiere Draws 5.3 Million Viewers HBO’s hit series “The…

April 14, 2025

You Might Also Like

The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings
Tech and Science

The New Scientist Book Club’s verdict on Our Brains, Our Selves: A mix of praise and misgivings

October 31, 2025
Tech Advisor December 2025 Digital Magazine
Tech and Science

Tech Advisor December 2025 Digital Magazine

October 31, 2025
Scientists Identified a New Blood Group After a 50-Year Mystery : ScienceAlert
Tech and Science

Scientists Identified a New Blood Group After a 50-Year Mystery : ScienceAlert

October 31, 2025
Nanotyrannus Isn’t a Juvenile T-Rex—It’s a Separate Dinosaur
Tech and Science

Nanotyrannus Isn’t a Juvenile T-Rex—It’s a Separate Dinosaur

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?